Search Results - "Krilis, S A"

Refine Results
  1. 1

    International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) by MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., REBER, G., SHOENFELD, Y., TINCANI, A., VLACHOYIANNOPOULOS, P. G., KRILIS, S. A.

    Published in Journal of thrombosis and haemostasis (01-02-2006)
    “…New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome…”
    Get full text
    Journal Article Conference Proceeding
  2. 2
  3. 3

    In vivo modulation of angiogenesis by beta 2 glycoprotein I by Passam, F.H, Qi, J.C, Tanaka, K, Matthaei, K.I, Krilis, S.A

    Published in Journal of autoimmunity (01-11-2010)
    “…Abstract Beta 2 glycoprotein I (β2GPI) is the major auto antigen in the antiphospholipid syndrome but also interacts with fibrinolytic and angiogenic proteins…”
    Get full text
    Journal Article
  4. 4

    Mast‐cell growth and differentiation by Li, L, Krilis, SA

    Published in Allergy (Copenhagen) (01-04-1999)
    “…Abbreviations. MC: mast cell; T: tryptase; C: chymase; CPA: carboxypeptidase A; Bsp‐1: basophil specific antibody 1…”
    Get full text
    Journal Article
  5. 5

    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk by Krilis, M., Qi, M., Ioannou, Y., Zhang, J.Y., Ahmadi, Z., Wong, J.W.H., Vlachoyiannopoulos, P.G., Moutsopoulos, H.M., Koike, T., Sturgess, A.D., Chong, B.H., Krilis, S.A., Giannakopoulos, B.

    Published in Journal of autoimmunity (01-08-2021)
    “…Β2-Glycoprotein I (β2GPI) is an important anti-thrombotic protein and is the major auto-antigen in the antiphospholipid syndrome (APS). The clinical relevance…”
    Get full text
    Journal Article
  6. 6

    Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post‐translational modification of beta 2 glycoprotein I by PASSAM, F. H., GIANNAKOPOULOS, B., MIRARABSHAHI, P., KRILIS, S. A.

    Published in Journal of thrombosis and haemostasis (01-07-2011)
    “…It has been well established that antiphospholipid antibodies and specifically those directed against beta 2 glycoprotein I (β2GPI) are pathogenic for the…”
    Get full text
    Journal Article
  7. 7

    Immunology and clinical importance of antiphospholipid antibodies by McNeil, H P, Chesterman, C N, Krilis, S A

    Published in Advances in immunology (1991)
    “…Having reviewed the literature on the association of aPL antibodies with clinical manifestations, it is clear that this group of autoantibodies are of…”
    Get more information
    Journal Article
  8. 8

    Risk stratification and outcome of cellulitis admitted to hospital by Figtree, M, Konecny, P, Jennings, Z, Goh, C, Krilis, S.A, Miyakis, S

    Published in The Journal of infection (01-06-2010)
    “…Summary Objectives To identify risk factors associated with mortality and adverse outcome of community acquired cellulitis/erysipelas requiring hospital…”
    Get full text
    Journal Article
  9. 9

    Redox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1 by PASSAM, F. H., RAHGOZAR, S., QI, M., RAFTERY, M. J, WONG, J. W. H., TANAKA, K., IOANNOU, Y., ZHANG, J. Y., GEMMELL, R., QI, J. C., GIANNAKOPOULOS, B., HUGHES, W. E., HOGG, P. J., KRILIS, S. A.

    Published in Journal of thrombosis and haemostasis (01-08-2010)
    “…Background: β2‐Glycoprotein I (β2GPI) is an abundant plasma protein that is closely linked to blood clotting, as it interacts with various protein and cellular…”
    Get full text
    Journal Article
  10. 10

    A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection by Hunt, J E, McNeil, H P, Morgan, G J, Crameri, R M, Krilis, S A

    Published in Lupus (01-02-1992)
    “…Anticardiolipin antibodies (aCL) purified from patients with autoimmune disease have recently been shown to interact with a phospholipid-binding plasma…”
    Get more information
    Journal Article
  11. 11

    Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjögren's syndrome by Skopouli, F N, Li, L, Boumba, D, Stefanaki, S, Hanel, K, Moutsopoulos, H M, Krilis, S A

    Published in Clinical and experimental rheumatology (01-01-1998)
    “…To determine the distribution and density of mast cells in the minor salivary glands of patients with primary Sjögren's syndrome (pSS) and of normal controls…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population by Shi, W, Krilis, S A, Chong, B H, Gordon, S, Chesterman, C N

    “…This study was designed to explore the incidence of lupus anticoagulant (LA) and anticardiolipin antibodies (ACA) and their relationship to each other in a…”
    Get more information
    Journal Article
  15. 15

    Identification of a Region of β2-Glycoprotein I Critical for Lipid Binding and Anti-Cardiolipin Antibody Cofactor Activity by Hunt, J. E., Simpson, R. J., Krilis, S. A.

    “…β2-Glycoprotein I (β2-GPI), a phospholipid-binding plasma protein, is an absolute requirement (cofactor) for the binding of autoimmune-type anti-cardiolipin…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Laboratory detection of antiphospholipid antibodies by Kandiah, D A, Krilis, S A

    Published in Lupus (01-04-1996)
    “…'Antiphospholipid' (aPL) antibodies are a heterogenous group of autoantibodies that are now considered to be directed mainly to plasma proteins or…”
    Get more information
    Journal Article
  18. 18

    Immunology of antiphospholipid antibodies and their interaction with plasma proteins by Kandiah, D A, Krilis, S A

    Published in Lupus (01-04-1996)
    “…'Antiphospholipid' (aPL) antibodies are of clinical importance because of their strong association with vascular thrombosis, recurrent pregnancy loss,…”
    Get more information
    Journal Article
  19. 19

    Anti-β2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding by Reddel, S W, Wang, Y X, Krilis, S A

    Published in Lupus (01-01-2003)
    “…Autoantibodies binding β2-glycoprotein I (B2GPI) are an important finding in the antiphospholipid syndrome. While antibodies from mice or rabbits immunized…”
    Get full text
    Journal Article
  20. 20

    Modulation of endothelial cell function by antiphospholipid antibodies by Meroni, P L, Del Papa, N, Beltrami, B, Tincani, A, Balestrieri, G, Krilis, S A

    Published in Lupus (01-10-1996)
    “…beta 2-glycoprotein I (beta 2-GP-I) the plasma cofactor for anti-phospholipid antibodies adheres on the endothelial surfaces and can be recognized by anti-beta…”
    Get more information
    Journal Article